Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

This publication has 30 references indexed in Scilit:

• 415 Amifostine preserves the salivary gland function during irradiation of the head and neck
  European Journal Of Cancer, 1995
• Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action
  Carcinogenesis: Integrative Cancer Research, 1995
• Radiation-Induced Lung Injury Using a Pig Model
  Investigative Radiology, 1995
• The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Use of radiation with or without WR-2721 in advanced rectal cancer
  Cancer, 1992
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Pharmacokinetics of WR-2721
  Pharmacology & Therapeutics, 1988
• Mechanism of Action of Aminothiol Radioprotectors
  Nature, 1967